News
Urogen's Zusduri is the first non-surgical therapy to be approved for NMIBC, setting a new standard for the indication.
SHANGHAI -- A Shanghai-based medical-device firm has launched clinical trials for its innovative CT scanner, which decodes ...
Company opts not to advance VX-993 into pivotal development after Phase II data show no statistically significant benefit ...
Using genetic screening, scientists have found a new drug combination that works against some treatment-resistant lung, brain and pancreatic cancers.
Clinical trials face challenges with variability in echo images, protocol adherence, and data quality. This discussion ...
Now, it’s worth noting Stock Advisor’s total average return is 1,019% — a market-crushing outperformance compared to 178 % ...
Nations that lead in clinical trials get earlier access to breakthrough therapies, shape global regulatory norms, and ...
Researchers are getting in touch with community groups in the Humber region to seek their help in clinical trials. The ...
1d
News Nation on MSNGates Foundation promises $2.5B for ‘sidelined’ women’s healthThough $2.5 billion sounds like it would go a long way toward addressing the gender health gap, Dr. Anita Zaidi, head of ...
These images are persistent, but far from the truth. In my years of experience working with clinical trials, I’ve learned that while some of the concerns people have are valid, many are rooted ...
MASH clinical trials test treatments for metabolic dysfunction-associated steatohepatitis, focusing on reversing liver inflammation, fibrosis, and fat accumulation safely.
The global market for AI in clinical trials is predicted to grow from $ 1.42 billion in 2023 to $8.5 billion by 2035.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results